A research team headed by scientists at University of California San Diego School of Medicine and the Ludwig Institute for Cancer Research at UC San Diego has identified an enzyme involved in remodelling the plasma membrane of multiple cancer cell types that is critical to both survival of tumours and their uncontrolled growth. The finding, published in the July 11, 2019 issue of Cell Metabolism, suggests a potential target for new drugs.
